Randomised, double-blind, placebo-controlled, Phase IIb/Phase III study to evaluate the efficacy and safety of spesolimab in patients with moderate to severe hidradenitis suppurativa. Lunsayil 1.

Project: Research

Project Details

StatusActive
Effective start/end date24/06/23 → 24/06/25

Keywords

  • clinical trial
  • Dermatology
  • hidradenitis suppurativa
  • acne